1-19 of 19
Pradip K. Majumder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Editor’s Note: Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells

Raanan Berger, Phillip G. Febbo, Pradip K. Majumder, Jean J. Zhao, Shayan Mukherjee, Sabina Signoretti, K. Thirza Campbell, William R. Sellers, Thomas M. Roberts, Massimo Loda, Todd R. Golub, William C. Hahn
Journal: Cancer Research
Cancer Res (2024) 84 (15): 2561.
https://doi.org/10.1158/0008-5472.CAN-24-1910
Published: 01 August 2024
View articletitled, Editor’s Note: Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells
Open the PDF for Editor’s Note: Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells in another window
Journal Articles

Abstract 5383: Dexter࣪ microfluidic platform spatially resolves antigen presentation and T cell functions in microdroplets and deciphers dynamic tumor-immune interaction network

Ashwin Lal, Ranjeet Singh, Abhay Sane, Rushil Manglik, Ravi R. Keshari, SM Mohanasundaram, Pradip K. Majumder, Biswanath Majumder
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5383.
https://doi.org/10.1158/1538-7445.AM2022-5383
Published: 15 June 2022
View articletitled, Abstract 5383: Dexter࣪ microfluidic platform spatially resolves antigen presentation and T cell functions in microdroplets and deciphers dynamic tumor-immune interaction network
Journal Articles

Abstract 3212: Patient-level pharmacodynamics of response to combined ipilimumab and nivolumab for gastric cancer using a human autologous ex-vivo platform, CANscript

Vidushi Kapoor, Munisha Smalley, Nandini Pal Basak, Abhishek Basu, Manjusha Biswas, Manas Kumar Mandal, Pinaki Roy, Pradip K. Majumder, Aaron Goldman
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3212.
https://doi.org/10.1158/1538-7445.AM2019-3212
Published: 01 July 2019
View articletitled, Abstract 3212: Patient-level pharmacodynamics of response to combined ipilimumab and nivolumab for gastric cancer using a human autologous ex-vivo platform, CANscript
Journal Articles

Abstract 5129: Delineating immune networks in colorectal cancers to predict effects of immune checkpoint inhibitors using CANScript platform technology preserving tumor immune microenvironment

Pradip K. Majumder, Nilesh Brijwani, Nikita N. Karandikar, Vinod D. Radhakrishna, Muthusamy Oliyarasi, Dency D. Pinto, Babu Balakrishnan, Vasathakumar Sekar, Manoj Rajappa, Debapriya G. Mehrotra, Priyanka Chevur, Priyanka Chevur, Arkasubhra Ghosh, Saravanan Thyiagarajan, Padhma Radhakrishnan, Biswanath Majumder
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 5129.
https://doi.org/10.1158/1538-7445.AM2016-5129
Published: 15 July 2016
View articletitled, Abstract 5129: Delineating immune networks in colorectal cancers to predict effects of immune checkpoint inhibitors using CANScript platform technology preserving tumor immune microenvironment
Journal Articles

Abstract 3397: Intrinsic factors from patient's tumor help neovascularization in an ex vivo platform

Baraneedharan Ulaganathan, Allen Thayakumar B, Manoj Rajappa, Ayyappan Velu, Arun Prasath, Kamal Ameer, Nilesh Brijwani, Padhma Radhakrishnan, Biswanath Majumder, Pradip K. Majumder, Saravanan Thiyagarajan
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3397.
https://doi.org/10.1158/1538-7445.AM2016-3397
Published: 15 July 2016
View articletitled, Abstract 3397: Intrinsic factors from patient's tumor help neovascularization in an ex vivo platform
Journal Articles

Abstract 5121: Immunomodulating cytokine profiling of docetaxel-treated human prostate cancer specimens

Debapriya G. Mehrotra, Nilesh Brijwani, Biplab Tewary, Vasathkumar Sekar, Abhishek Krishnan, Dency D. Pinto, Muthusamy Oliyarasi, Biswanath Majumder, Saravanan Thiyagarajan, Padhma Radhakrishnan, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 5121.
https://doi.org/10.1158/1538-7445.AM2016-5121
Published: 15 July 2016
View articletitled, Abstract 5121: Immunomodulating cytokine profiling of docetaxel-treated human prostate cancer specimens
Journal Articles

Abstract 1304: Identification of responders for Anti-CTLA4 in refractory colorectal cancers using CANScript™ platform

Biswanath Majumder, Baraneedharan Ulaganathan, Allen Thayakumar, Saravanan Thiyagarajan, Nilesh Brijwani, Biplab Tewari, Basavaraja U. Santhappa, Padhma Radhakrishnan, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1304.
https://doi.org/10.1158/1538-7445.AM2015-1304
Published: 01 August 2015
View articletitled, Abstract 1304: Identification of responders for Anti-CTLA4 in refractory colorectal cancers using CANScript™ platform
Journal Articles

Abstract 3736: Application of patient tumors-derived tumor ecosystem platform for the development of novel HDAC inhibitor in solid cancers

Mallikarjun Sundaram, Baraneedharan Ulaganathan, Muthu Dhandapani, Allen Thayakumar, Pragnashree Mukhopadhyay, Saravanan Thiyagarajan, Biswanath Majumder, Prasad Shivarudriah, H Jagadheshan, Ganesh Sambasivam, Steve Birnbuam, Padhma Radhakrishnan, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3736.
https://doi.org/10.1158/1538-7445.AM2014-3736
Published: 01 October 2014
View articletitled, Abstract 3736: Application of patient tumors-derived tumor ecosystem platform for the development of novel HDAC inhibitor in solid cancers
Journal Articles

Abstract 2051: PAT-1102, a novel HDAC inhibitor exhibits potent anti-tumor efficacy in patient-derived refractory solid tumors.

Padhma Radhakrishnan, Muthu Dhandapani, Baraneedharan Ulaganathan, Allen Thayakumar, Saravanan Thiyagarajan, Dency Pinto, D R. Vinod, Biswanath Majumder, Prasad Shivarudriaah, H Jagadheshan, Ganesh Sambasivam, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2051.
https://doi.org/10.1158/1538-7445.AM2013-2051
Published: 15 April 2013
View articletitled, Abstract 2051: PAT-1102, a novel HDAC inhibitor exhibits potent anti-tumor efficacy in patient-derived refractory solid tumors.
Journal Articles

Abstract 4947: Inhibition of Rapamycin induced AKT activation elicits differential anti-tumor response in head and neck cancers.

Padhma Radhakrishnan, Ulaganathan Baraneedharan, Muthu Dhandapani, Allen Thyakumar, Dency Pinto, Arun Prasath, Ayyappan Velu, A Kamal, Nilesh Brijwani, Rohini Nair, R Basavaraja, Misti Jain, Saravanan Thiyagarajan, Biswanath Majumder, Mallik Sundaram, Prasad Narayanan, Vikram D. Kekatpure, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4947.
https://doi.org/10.1158/1538-7445.AM2013-4947
Published: 15 April 2013
View articletitled, Abstract 4947: Inhibition of Rapamycin induced AKT activation elicits differential anti-tumor response in head and neck cancers.
Journal Articles

Abstract 5072: Human tumor derived Oncoprint® platform predicts molecular mechanism of sensitivity and resistance to Fragmin in pancreatic cancer.

Mallikarjun Sundaram, Saravanan Thiyagarajan, Muthu Dhandapani, Nilesh Brijwani, Arun Prasath, Allen Thayakumar, Ameer Kamal, Padhma Radhakrishnan, Biswanath Majumder, Baraneedharan Ulaganathan, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5072.
https://doi.org/10.1158/1538-7445.AM2013-5072
Published: 15 April 2013
View articletitled, Abstract 5072: Human tumor derived Oncoprint® platform predicts molecular mechanism of sensitivity and resistance to Fragmin in pancreatic cancer.
Journal Articles

Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers

Padhma Radhakrishnan, Ulaganathan Baraneedharan, Subhadra Veluchamy, Muthu Dhandapani, Dency D. Pinto, Saravanan Thiyagarajan, Allen Thayakumar, Arun Prasath, Kamal A, Ayyappan Velu, Misti Jain, Nilesh Brijwani, Prasad Narayanan, Vikram D. Kekatpure, Biswanath Majumder, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (3): 1118–1127.
https://doi.org/10.1158/0008-5472.CAN-12-2545
Published: 31 January 2013
View articletitled, Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers
Open the PDF for Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers in another window
Journal Articles

Abstract 3191: Primary human tumor-derived Oncoprint platform predicts molecular mechanism of sensitivity and resistance to anti-EGFR in colorectal cancer: A step towards personalized cancer medicine

Misti Jain, Farrah Zahed, Arun Prasath, Muthu Dhandapani, Subhadra Veluchamy, A Kamal, Padhma Radhakrishnan, Saravanan Thiyagarajan, Rajagopalan Surendran, Biswanath Mazumder, Mallik Sundaram, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3191.
https://doi.org/10.1158/1538-7445.AM2012-3191
Published: 15 April 2012
View articletitled, Abstract 3191: Primary human tumor-derived Oncoprint platform predicts molecular mechanism of sensitivity and resistance to anti-EGFR in colorectal cancer: A step towards personalized cancer medicine
Journal Articles

Abstract LB-284: Combination of antiandrogens and PI3-kinase pathway inhibitors in a model of androgen-dependent prostate cancer

Clay Efferson, Joe Zhu, Chris Ware, Jennifer Tammam, Minilik Angagaw, John F. Reilly, Cyrille Sur, Edwin Clark, Chris Winter, Weisheng Zhang, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-284.
https://doi.org/10.1158/1538-7445.AM10-LB-284
Published: 15 April 2010
View articletitled, Abstract LB-284: Combination of antiandrogens and PI3-kinase pathway inhibitors in a model of androgen-dependent prostate cancer
Journal Articles

Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model

Clay L. Efferson, Christopher T. Winkelmann, Christopher Ware, Timothy Sullivan, Saverio Giampaoli, Jennifer Tammam, Shailendra Patel, Giuseppe Mesiti, John F. Reilly, Raymond E. Gibson, Carolyn Buser, Timothy Yeatman, Domenico Coppola, Christopher Winter, Edwin A. Clark, Giulio F. Draetta, Peter R. Strack, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2010) 70 (6): 2476–2484.
https://doi.org/10.1158/0008-5472.CAN-09-3114
Published: 14 March 2010
View articletitled, Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model
Open the PDF for Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model in another window
Includes: Supplementary data
Journal Articles

De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model

James W. Watters, Chun Cheng, Pradip K. Majumder, Ruojie Wang, Sireesha Yalavarthi, Carol Meeske, Lingxin Kong, Wenping Sun, Jie Lin, Joerg Heyer, Chris Ware, Christopher Winter, John F. Reilly, Tim Demuth, Steve Clark, M. Isabel Chiu, Murray O. Robinson, Nancy Kohl, Karuppiah Kannan
Journal: Cancer Research
Cancer Res (2009) 69 (23): 8949–8957.
https://doi.org/10.1158/0008-5472.CAN-09-1544
Published: 30 November 2009
View articletitled, De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model
Open the PDF for De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model in another window
Includes: Supplementary data
Journal Articles

Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer

Weisheng Zhang, Joe Zhu, Clay L. Efferson, Chris Ware, Jennifer Tammam, Minilik Angagaw, Jason Laskey, Kimberly A. Bettano, Shailaja Kasibhatla, John F. Reilly, Cyrille Sur, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2009) 69 (18): 7466–7472.
https://doi.org/10.1158/0008-5472.CAN-08-4385
Published: 14 September 2009
View articletitled, Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer
Open the PDF for Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells

Raanan Berger, Phillip G. Febbo, Pradip K. Majumder, Jean J. Zhao, Shayan Mukherjee, Sabina Signoretti, K. Thirza Campbell, William R. Sellers, Thomas M. Roberts, Massimo Loda, Todd R. Golub, William C. Hahn
Journal: Cancer Research
Cancer Res (2004) 64 (24): 8867–8875.
https://doi.org/10.1158/0008-5472.CAN-04-2938
Published: 16 December 2004
View articletitled, Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells
Open the PDF for Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells in another window
Includes: Supplementary data
Journal Articles

In vivo inhibition of the mTOR pathway and reversal of Akt-dependent prostate intraepithelial neoplasia requires induction of mitochondrial pathway mediated cell-death

Pradip K. Majumder, Rachel Bikoff, Raanan Berger, Qi Xue, Judy Shim, Nandita Bhattacharya, Judith Manola, Louis McMahon, Timothy J. McDonnell, Massimo Loda, Heidi A. Lane, William R. Sellers
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1183.
Published: 01 April 2004
View articletitled, In vivo inhibition of the mTOR pathway and reversal of Akt-dependent prostate intraepithelial neoplasia requires induction of mitochondrial pathway mediated cell-death